TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma

NCT03722342 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DRUG: TTAC-0001 and pembrolizumab combination

Sponsor

PharmAbcine